Neurodevelopmental Outcomes in Children With Congenital Heart Disease-What Can We Impact?

Gil Wernovsky1, Daniel J Licht

  • 11Department of Pediatrics, Section of Cardiology, Florida International University, Wertheim College of Medicine, Nicklaus Children's Hospital, Miami, FL. 2Department of Pediatrics, Section of Cardiology, Perelman School of Medicine, University of Pennsylvania, Children's Hospital of Philadelphia Philadelphia, PA.

Insights

Neurologic injuries in newborns with congenital heart disease are common. Research is ongoing to understand brain development, identify risk factors, and improve long-term outcomes.

Area of Science:

  • Pediatric Neurology
  • Neonatal Cardiology
  • Developmental Neuroscience

Background:

  • Congenital heart disease (CHD) poses significant risks for neurologic injury in newborns.
  • Understanding the mechanisms of injury, from prenatal to postoperative factors, is crucial for intervention.

Purpose of the Study:

  • To review the scope and mechanisms of neurologic injuries in newborns with CHD.
  • To discuss neurodevelopmental outcomes and therapeutic strategies for prevention and intervention.
  • To highlight ongoing research aimed at improving long-term outcomes and quality of life.

Main Methods:

  • Literature review of MEDLINE and PubMed databases.
  • Synthesis of current research on fetal brain development in CHD.
  • Analysis of risk factors and therapeutic interventions.

Main Results:

  • Neurologic injuries are a significant concern in neonates with CHD.
  • Prenatal, perioperative, and postoperative factors contribute to brain injury.
  • Long-term neurodevelopmental outcomes are a critical area of ongoing research.

Conclusions:

  • Further research is essential to understand the fetal brain in CHD and identify modifiable risk factors.
  • Developing early postoperative surrogate variables is key for effective clinical trials.
  • Improving family psychosocial health and childhood development post-discharge is a priority.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
618
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.1K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.4K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
716
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
781